Related Experiment Video
Updated: Jun 26, 2026

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits
Published on: February 28, 2025
Is shock a key element in the pathology of sudden infant death syndrome (SIDS)?
Jane Blood-Siegfried1, Margaret T Bowers, Marcia Lorimer
1School of Nursing, Duke University, Durham, North Carolina 27710, USA. blood002@mc.duke.edu
Insights
Sudden Infant Death Syndrome (SIDS) is multifactorial. Research suggests shock and cardiovascular collapse may link SIDS theories involving infant vulnerability, developmental stage, and external stressors like infection or nicotine exposure.
Area of Science:
- Pediatrics
- Neonatology
- Cardiovascular Research
Background:
- Sudden Infant Death Syndrome (SIDS) is the leading cause of post-neonatal infant mortality in developed nations.
- Current SIDS models, including the triple-risk model, fatal triangle, and common bacterial hypothesis, highlight multifactorial causes involving infant vulnerability, critical developmental periods, and external stressors.
- Existing theories often focus on specific stressors like prone sleeping, hypoxia, infection, or inflammation, but a unifying mechanism is lacking.
Purpose of the Study:
- To propose a unifying mechanism linking existing SIDS etiological theories.
- To investigate the role of shock and cardiovascular collapse in SIDS pathogenesis.
- To explore how perinatal nicotine exposure exacerbates SIDS risk in an animal model.
Main Methods:
- Utilized an animal model (rat pups) to study SIDS-related mortality.
- Investigated the impact of infectious insults during critical developmental periods.
- Examined the effects of perinatal nicotine exposure on autonomic responses and SIDS outcomes.
Main Results:
- Rat pups exposed to infectious insults during a critical developmental window exhibited mortality.
- Perinatal nicotine exposure exacerbated mortality in this model, altering autonomic responses.
- Findings suggest shock and cardiovascular collapse are key events linking various SIDS risk factors.
Conclusions:
- Shock and cardiovascular collapse represent a potential unifying mechanism for SIDS.
- This mechanism integrates infant vulnerability, developmental timing, and external stressors like infection and nicotine exposure.
- Further research is warranted to validate these findings in human infants and refine SIDS prevention strategies.
Abstract:
In developed countries, sudden infant death syndrome (SIDS) is the most common cause of death for infants between 1 month and 1 year of age. The etiology of SIDS is likely to be multifactorial, and current paradigms often describe three overlapping elements of risk. Those elements are a critical developmental period, a vulnerable infant, and one or more exogenous stressors. In the triple-risk model, SIDS infants are described as having an underlying vulnerability in cardiorespiratory control in the central nervous system during a critical period when autonomic control is developing. This vulnerability might affect the response to exogenous stressors, including prone sleeping position, hypoxia, and increased carbon dioxide. In the common bacterial hypothesis and fatal triangle, the focus is on the stressors. In the first, a combination of common respiratory infections can cause SIDS in an infant during a developmentally vulnerable period. This theory also includes 3 factors of vulnerability: a genetic predisposition, a vulnerable developmental age, and infectious stressors. In the fatal triangle theory, infection, inflammation, and genetics each play a role in triggering a SIDS fatality. From our work in an animal model, we have found that rat pups die from a combination of infectious insults during a critical time of development. This is exacerbated by perinatal nicotine exposure, a condition shown to alter the autonomic response in exposed offspring. We are proposing that shock and cardiovascular collapse is a key element that links these theories.
More Related Videos
Related Concept Videos
Respiratory Syncytial Virus Disease
Depolarizing Blockers: Pharmocokinetics

